Suppr超能文献

11β-羟基类固醇脱氢酶对气道上皮细胞中氢化可的松作用的调节

Regulation of the action of hydrocortisone in airway epithelial cells by 11beta-hydroxysteroid dehydrogenase.

作者信息

Feinstein M B, Schleimer R P

机构信息

Johns Hopkins Asthma and Allergy Center, Baltimore, Maryland, USA.

出版信息

Am J Respir Cell Mol Biol. 1999 Sep;21(3):403-8. doi: 10.1165/ajrcmb.21.3.3560.

Abstract

11beta-hydroxysteroid dehydrogenase (11betaHSD) reversibly converts hydrocortisone, the predominant active endogenous glucocorticoid in humans, to its inactive metabolite cortisone by oxidizing the 11-hydroxy group to an 11-keto group. Because this enzyme is highly expressed in human bronchial epithelial cells, we hypothesized that it regulates epithelial responses to glucocorticoids by reducing levels of hydrocortisone available to bind to the glucocorticoid receptor. Primary human bronchial epithelial cells (PBECs) were isolated from seven autopsy specimens and cultured in F12/Dulbecco's modified Eagle's medium with 5% fetal bovine serum until approximately 80% confluent. Cells were preincubated with 10(-9) M to 10(-5) M hydrocortisone for 24 h in the presence or absence of 10(-6) M of the 11betaHSD inhibitor glycyrrhetinic acid, after which the cells were stimulated with 5 ng/ml interleukin-1beta for 24 h. Granulocyte macrophage colony-stimulating factor (GM-CSF) levels were quantitated in the resulting supernatants by enzyme-linked immunosorbent assay. Hydrocortisone inhibited GM-CSF release in stimulated PBEC with a concentration that produces 50% inhibition of maximum effect (IC(1/2)max) of 5.0 x 10(-8) M. In the presence of glycyrrhetinic acid, the potency of hydrocortisone was increased approximately 33-fold (IC(1/2)max with glycyrrhetinic acid, 1.5 x 10(-9) M). Hydrocortisone activity was maximally enhanced at concentrations between 10(-9) M and 10(-8) M, levels that are comparable to plasma levels of hydrocortisone not bound to plasma proteins. Glycyrrhetinic acid had no effect on the suppression of GM-CSF release by hydrocortisone in the transformed cell line BEAS-2B, which does not express the 11betaHSD enzyme. Glycyrrhetinic acid also had no effect on the inhibition of GM-CSF release in PBECs by the synthetic glucocorticoids budesonide, beclomethasone dipropionate, fluticasone propionate, mometasone furoate, and triamcinolone acetonide, steroids not metabolized by 11betaHSD. Together, these findings suggest that metabolism of hydrocortisone by 11betaHSD may regulate glucocorticoid activity in human airway epithelial cells.

摘要

11β-羟基类固醇脱氢酶(11βHSD)通过将11-羟基氧化为11-酮基,将人体中主要的活性内源性糖皮质激素氢化可的松可逆地转化为其无活性代谢产物可的松。由于该酶在人支气管上皮细胞中高度表达,我们推测它通过降低可与糖皮质激素受体结合的氢化可的松水平来调节上皮细胞对糖皮质激素的反应。从7份尸检标本中分离出原代人支气管上皮细胞(PBECs),并在含有5%胎牛血清的F12/杜尔贝科改良伊格尔培养基中培养,直至细胞汇合度约为80%。在存在或不存在10⁻⁶ M的11βHSD抑制剂甘草次酸的情况下,将细胞与10⁻⁹ M至10⁻⁵ M的氢化可的松预孵育24小时,之后用5 ng/ml白细胞介素-1β刺激细胞24小时。通过酶联免疫吸附测定法定量测定所得上清液中的粒细胞巨噬细胞集落刺激因子(GM-CSF)水平。氢化可的松以5.0×10⁻⁸ M的半数最大抑制浓度(IC₁/₂max)抑制刺激后的PBEC中GM-CSF的释放。在存在甘草次酸的情况下,氢化可的松的效力增加了约33倍(甘草次酸存在时的IC₁/₂max为1.5×10⁻⁹ M)。氢化可的松活性在10⁻⁹ M至10⁻⁸ M之间的浓度下最大程度增强,该浓度与未与血浆蛋白结合的氢化可的松的血浆水平相当。甘草次酸对不表达11βHSD酶的转化细胞系BEAS-2B中氢化可的松对GM-CSF释放的抑制作用没有影响。甘草次酸对合成糖皮质激素布地奈德、二丙酸倍氯米松、丙酸氟替卡松、糠酸莫米松和曲安奈德对PBECs中GM-CSF释放的抑制作用也没有影响,这些类固醇不会被11βHSD代谢。总之,这些发现表明11βHSD对氢化可的松的代谢可能调节人气道上皮细胞中的糖皮质激素活性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验